European Surveillance System on Contact Allergies (<scp>ESSCA</scp>): results with the European baseline series, 2013/14

Uter, Wolfgang; Amario-Hita, J.C.; Balato, Anna; Ballmer‐Weber, Barbara; Bauer, Andrea; Fortina, Anna Belloni; Bircher, Andreas J.; Chowdhury, M. M. U.; Cooper, Susan M.; Czarnecka‐Operacz, Magdalena; Dugonik, Aleksandra; Gallo, Rosella; Giménez‐Arnau, Ana; Johansen, Jeanne Duus; John, Swen Malte; Kieć-Swierczyńska, M; Kmecl, Tanja; Krêcisz, Beata; Filon, Francesca Larese; Mahler, Vera; Pesonen, Maria; Rustemeyer, Thomas; Sadowska‐Przytocka, Anna; Sánchez‐Pérez, Javier; Schliemann, Sibylle; Schuttelaar, Marie L A; Simon, Dagmar; Śpiewak, Radosław; Valiukevičienė, Skaidra; Weißhaar, Elke; White, Ian R.; Wilkinson, S. M.

doi:10.1111/jdv.14423

Cited by 114 publications

(130 citation statements)

References 44 publications

Supporting

Mentioning

111

Contrasting

Unclassified

Order By: Relevance

“…Although the prevalence of MCI/MI contact allergy in patch test populations remained relatively stable at 2.5% for a long period of time, recent publications have shown it to be rapidly rising (). The most recent publication of the European Surveillance System on Contact Allergies (ESSCA) showed a standardized prevalence of 7.3% for contact allergy to MCI/MI 0.01% in 2013–2014, which is similar to our results .…”

Section: Discussionsupporting

confidence: 91%

Comparing patch test results of methylchloroisothiazolinone/methylisothiazolinone tested with both TRUE Test® and 100 ppm using investigator‐loaded chambers

Dittmar

Schuttelaar

2018

Contact Dermatitis

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 91%

Comparing patch test results of methylchloroisothiazolinone/methylisothiazolinone tested with both TRUE Test® and 100 ppm using investigator‐loaded chambers

Dittmar

Schuttelaar

2018

Contact Dermatitis

View full text Add to dashboard Cite

“…After age, OCD was most strongly associated with polysensitization, with a PR of 1.57. Certain countries contributed a higher proportion of OCD than others, for example Germany, Finland, and Poland, all three of which have contributions from departments specialized in occupational dermatology . A higher percentage of occupational aetiology of dermatitis in the polysensitized population than in the total patch tested population can be seen in all countries, except for Finland, where only 34.8% of the polysensitized group had OCD, as compared with 47.6% of all tested individuals.…”

Section: Discussionmentioning

confidence: 93%

European Surveillance System on Contact Allergies (ESSCA): polysensitization, 2009–2014

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Cobalt is a strong skin sensitizer, and an estimated 5.9% and 7.4% of patch tested dermatitis patients in Europe and North America, respectively, are cobalt‐allergic . However, clinical relevance is often difficult to determine, and previous identification of occupational and consumer sources of cobalt seems to be insufficient.…”

Section: Introductionmentioning

confidence: 99%

Causative exposures and temporal development of cobalt allergy in Denmark between 2002 and 2017

et al. 2019

View full text Add to dashboard Cite

Background Cobalt contact allergy is common, but clinical relevance is often difficult to determine. Objectives To examine the aetiology, prevalence and clinical characteristics of cobalt‐allergic patients who were patch tested between 2002 and 2017 at the Department of Dermatology and Allergy, Herlev‐Gentofte Hospital. Methods Patch test data, along with patient characteristics and causative exposures, from all adult dermatitis patients seen and tested between 2002 and 2017 were analysed. Associations were tested with the χ 2 test and logistic regression. Results A total of 13 475 adults aged 18 to 99 years were patch tested. The overall prevalence of cobalt allergy and the prevalence of isolated cobalt allergy were 3.3% and 1.5%, respectively. The prevalence of isolated cobalt allergy decreased from 2.4% in 2006 to 2009 to 1.1% in 2014 to 2017 (Ptrend = 0.00003). Leather exposure as a relevant cause of allergic cobalt dermatitis increased from 3.7% in 2002 to 2009 to 8.3% in 2010 to 2017 (P = 0.04). The current clinical relevance of positive patch test reactions, that is, a positive reaction to cobalt combined with a history of current skin exposure to a source of cobalt, was 20.1%. Conclusions We conclude that cobalt allergy is relatively common, but causative exposures are largely unknown, and the proportion of positive patch test reactions with clinical relevance is low. It is therefore currently unclear how we can better protect consumers and workers from cobalt exposure.

show abstract

European Surveillance System on Contact Allergies (ESSCA): results with the European baseline series, 2013/14

Abstract: Continuous surveillance of contact allergy based on network data offers the identification of time trends or persisting problems, and thus enables focussing in-depth research (subgroup analyses, exposure analysis) on areas where it is needed.

Cited by 114 publications

References 44 publications

Comparing patch test results of methylchloroisothiazolinone/methylisothiazolinone tested with both TRUE Test® and 100 ppm using investigator‐loaded chambers

Comparing patch test results of methylchloroisothiazolinone/methylisothiazolinone tested with both TRUE Test® and 100 ppm using investigator‐loaded chambers

European Surveillance System on Contact Allergies (ESSCA): polysensitization, 2009–2014

Causative exposures and temporal development of cobalt allergy in Denmark between 2002 and 2017

Contact Info

Product

Resources

About